Opportunity Information: Apply for PA 07 436

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Bioengineering Approaches to Energy Balance and Obesity (STTR R41/R42)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.393 Cancer Cause and Prevention Research 93.399 Cancer Control 93.837 Cardiovascular Diseases Research 93.866 Aging Research.
  • This funding opportunity was created on Jan 26, 2009 and posted on Aug 20, 2007.
  • Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Small businesses Others (see text field entitled Additional Information on Eligibility for clarification).
  • Foreign institutions are not eligible to apply.
Apply for PA 07 436

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Bioengineering Approaches to Energy Balance and Obesity opportunity (PA 07-436) is a National Institutes of Health (NIH) funding announcement aimed at pushing forward new bioengineering technologies that can help researchers and clinicians better understand, measure, and ultimately influence the factors that drive energy balance. In practical terms, the program is focused on tools and methods that improve how energy intake and energy expenditure are assessed, monitored, and studied in real-world and clinical settings. The broader motivation is the ongoing public health burden of obesity and related chronic diseases, and the recognition that better instruments, sensors, and measurement platforms can unlock more accurate research findings and more effective interventions over time.

The core purpose of the announcement is technology development and validation. NIH is looking for novel sensors, devices, imaging methods, and other innovative bioengineering approaches that can address clinical problems linked to energy balance, including the biological and behavioral drivers of eating, physical activity, metabolism, and weight regulation. The expectation is that these technologies will not just be conceptual prototypes, but will be built and evaluated in ways that demonstrate they can produce useful, reliable data or capabilities for the obesity and nutrition research community. By increasing the number and quality of research tools available, the program aims to speed up scientific discovery in energy balance and health, and eventually contribute to therapeutic advances or practical behavioral strategies for weight control and obesity prevention and treatment.

A defining feature of this opportunity is its emphasis on collaboration across disciplines. Applicants are expected to bring together engineering and physical science expertise with domain knowledge in obesity, nutrition, and related biomedical fields. The announcement explicitly anticipates that engineers and physical scientists will work alongside investigators who understand the clinical and biological realities of obesity and energy balance, so that proposed technologies are grounded in real needs and can be meaningfully tested in relevant populations or experimental contexts. This interdisciplinary structure is intended to improve the odds that new tools are not only technically impressive, but also usable, interpretable, and impactful for health research.

This funding announcement uses the Small Business Technology Transfer (STTR) mechanisms, specifically R41 (Phase I) and R42 (Phase II), and it also accepts Fast-Track applications that combine Phase I and Phase II considerations into a streamlined path. STTR is designed for small businesses that are formally collaborating with a nonprofit research institution, with the goal of translating early-stage innovation into products or platforms that have a clear line of sight to real-world application. The announcement also notes that it runs in parallel with an identically scoped companion solicitation using the Small Business Innovation Research (SBIR) mechanisms (PA 07-435, R43/R44). The parallel structure signals that NIH is supporting the same scientific goals through two closely related small-business programs, giving applicants the option to pursue the route that best fits their partnership structure and commercialization plan.

On funding levels and award counts, NIH does not set a single fixed budget or number of awards for this opportunity. Instead, it states that award size and duration will vary depending on what is proposed, and that the total funding and number of awards will depend on the mix of mechanisms used, as well as the overall quality, duration, and costs of the submitted applications. In other words, proposals will be judged on merit and feasibility, and the final funding outcome will reflect the strength and scope of the applications NIH receives during the various receipt dates. The announcement also indicates there is no cost-sharing or matching requirement, which reduces barriers for small businesses that might otherwise struggle to commit non-federal funds.

Eligibility is centered on small businesses, with additional categories referenced in the full text, but a key limitation is that foreign institutions are not eligible to apply. The opportunity is categorized as a discretionary grant and is associated with multiple CFDA program areas, reflecting NIH-wide interest in technology that can influence or inform obesity-related research across several disease domains. Listed CFDA numbers include 93.286 (technology innovations to improve human health) as well as cancer-related programs (93.393 and 93.399), cardiovascular disease research (93.837), and aging research (93.866). This spread signals that NIH views improved energy balance technologies as broadly relevant, since obesity and metabolic health affect cancer risk, cardiovascular outcomes, and health during aging.

Administratively, the opportunity was posted on August 20, 2007, and it used multiple receipt dates (rather than a single deadline), with the details provided in the full announcement. The archived date is September 5, 2010, meaning the specific announcement is no longer active as written, though similar topics may reappear in newer NIH funding announcements. For applicants or interested parties who need the original documentation, the full announcement was hosted through the NIH Grants Guide (the link provided in the source text), and NIH’s Office of Extramural Research (OER) webmaster contact was listed for access or technical issues.

Overall, the opportunity is best understood as a translational, tool-building program targeted at small businesses working with research partners to create the next generation of measurement and intervention-enabling technologies for energy balance and obesity. The outcome NIH is trying to encourage is a pipeline of validated, practical tools that make obesity and nutrition research more precise and scalable, thereby supporting long-term progress toward better prevention strategies, better treatments, and more effective behavior change approaches.

Frequently Asked Questions (FAQs)

What is the "Bioengineering Approaches to Energy Balance and Obesity" opportunity (PA 07-436)?

PA 07-436 is a National Institutes of Health (NIH) funding announcement focused on advancing new bioengineering technologies that help researchers and clinicians better understand, measure, monitor, and influence energy balance in the context of obesity and related chronic diseases.

What is the main goal of this NIH funding announcement?

The core goal is technology development and validation. NIH is looking for novel tools (such as sensors, devices, imaging methods, and other bioengineering approaches) that can produce useful and reliable data or capabilities for obesity and nutrition research, with the longer-term intent of enabling better interventions and therapeutic or behavioral strategies.

What kinds of projects are a good fit for this program?

Projects that create and validate innovative bioengineering tools for assessing or studying energy intake, energy expenditure, physical activity, metabolism, eating behavior, and weight regulation in real-world and clinical settings are a strong fit. The emphasis is on practical, evaluable technologies rather than purely conceptual ideas.

Does NIH expect prototypes to be built and tested, or are early concepts acceptable?

The announcement emphasizes building and evaluating technologies in ways that demonstrate they can generate useful, reliable data or capabilities. This implies an expectation beyond concept-only proposals, with a focus on development and validation.

What clinical or research problems is NIH trying to address through this opportunity?

The opportunity targets clinical problems linked to energy balance and obesity, including biological and behavioral drivers of eating, physical activity patterns, metabolic processes, and mechanisms of weight regulation. The broader motivation is to improve obesity-related research and, over time, contribute to better prevention and treatment approaches.

Why does the announcement emphasize measurement and monitoring tools?

NIH highlights that better instruments, sensors, and measurement platforms can unlock more accurate research findings and enable more effective interventions. Improving how energy intake and energy expenditure are assessed and monitored is central to making obesity and energy balance research more precise and scalable.

Is this opportunity focused on basic science, translational work, or product-oriented development?

Based on the description, it is best understood as translational and tool-building, aimed at developing and validating technologies that can be used by the obesity and nutrition research community and that have a clear line of sight to real-world application.

What funding mechanisms are used for PA 07-436?

This announcement uses the Small Business Technology Transfer (STTR) mechanisms: R41 (Phase I) and R42 (Phase II). It also accepts Fast-Track applications that combine Phase I and Phase II considerations into a streamlined application path.

What is the role of STTR in this opportunity?

STTR is designed for small businesses that are formally collaborating with a nonprofit research institution, with the intent of translating early-stage innovation into products or platforms that can move toward real-world use.

Is there a related or companion NIH opportunity mentioned?

Yes. The announcement notes a parallel companion solicitation with the same scientific scope using the Small Business Innovation Research (SBIR) mechanisms: PA 07-435 (R43/R44).

How should an applicant decide between the STTR (PA 07-436) and the SBIR companion (PA 07-435)?

The description indicates NIH is supporting the same scientific goals through two closely related small-business programs, allowing applicants to choose the route that best fits their partnership structure and commercialization plan (with STTR explicitly built around a formal collaboration with a nonprofit research institution).

Who is eligible to apply?

Eligibility is centered on small businesses, consistent with the STTR mechanism. The text also notes additional categories may be referenced in the full announcement.

Are foreign institutions eligible to apply?

No. A key limitation stated is that foreign institutions are not eligible to apply.

Is cost-sharing or matching required?

No. The announcement indicates there is no cost-sharing or matching requirement.

How much funding is available per award?

NIH does not set a single fixed budget amount in the provided description. Award size and duration are expected to vary depending on what is proposed.

How many awards will NIH make under this opportunity?

The number of awards is not fixed. NIH indicates the total funding and number of awards will depend on the mix of mechanisms used and the overall quality, duration, and costs of submitted applications.

What factors influence final funding outcomes?

Based on the description, outcomes depend on the merit and feasibility of proposals, as well as the quality, duration, and costs of applications received across receipt dates, and on the mechanisms used (Phase I, Phase II, or Fast-Track).

Is this announcement connected to specific CFDA program areas?

Yes. The opportunity is associated with multiple CFDA program areas, reflecting broad NIH interest in technologies relevant to obesity and energy balance across disease domains.

Which CFDA numbers are listed in the provided description?

The listed CFDA numbers include 93.286 (technology innovations to improve human health), 93.393 and 93.399 (cancer-related programs), 93.837 (cardiovascular disease research), and 93.866 (aging research).

Why are cancer, cardiovascular, and aging CFDA areas mentioned for an obesity and energy balance technology program?

The description signals that NIH views improved energy balance technologies as broadly relevant because obesity and metabolic health can affect cancer risk, cardiovascular outcomes, and health during aging.

When was this opportunity posted, and is it still active?

It was posted on August 20, 2007. The archived date is September 5, 2010, which means this specific announcement is no longer active as written, though similar topics may appear in newer NIH funding announcements.

Did the opportunity use a single deadline or multiple receipt dates?

It used multiple receipt dates rather than a single deadline, with details provided in the full announcement.

Where could someone find the original full announcement?

The full announcement was hosted through the NIH Grants Guide (via the link provided in the source text). The NIH Office of Extramural Research (OER) webmaster contact was listed for access or technical issues.

What is the overall outcome NIH is trying to encourage?

The program aims to build a pipeline of validated, practical tools that make obesity and nutrition research more precise and scalable, supporting long-term progress toward better prevention strategies, better treatments, and more effective behavior change approaches.

Is interdisciplinary collaboration important for this opportunity?

Yes. A defining feature is the expectation that engineering and physical science expertise will be integrated with obesity, nutrition, and biomedical domain knowledge, so the resulting technologies address real needs and can be meaningfully tested in relevant contexts.

What kinds of teams does NIH expect applicants to form?

The announcement anticipates that engineers and physical scientists will work alongside investigators with clinical and biological expertise in obesity and energy balance, supporting both technical innovation and real-world usability and interpretability.

Browse more business programs for Engineering Companies, Bioengineering Companies

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: New Technology for Proteomics and Glycomics (SBIR R43/R44)

Previous opportunity: Bioengineering Approaches to Energy Balance and Obesity (SBIR R43/R44)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 436

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 436) also looked into and applied for these:

Funding Opportunity
Competing Renewal Awards of SBIR Phase II Grants for Brain and Behavior Tools (R44) Apply for PA 08 056

Funding Number: PA 08 056
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
New Technologies for Transient Molecular Complex Characterization (SBIR R43/R44) Apply for PA 08 110

Funding Number: PA 08 110
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
New Technologies for Transient Molecular Complex Characterization (STTR R41/R42) Apply for PA 08 111

Funding Number: PA 08 111
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Probes and Instrumentation for Monitoring and Manipulating Nervous System Plasticity (SBIR R43/R44) Apply for PA 08 146

Funding Number: PA 08 146
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Pharmacogenomics Research Network (U01/U19) Apply for RFA GM 10 001

Funding Number: RFA GM 10 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Energy Efficiency and Renewable Energy System Technology Research and Development (STTR R41/R42) Apply for PA 09 101

Funding Number: PA 09 101
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR R43/R44) Apply for PA 09 100

Funding Number: PA 09 100
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mechanisms of Alcohol and Nicotine Co Dependence (R21) Apply for PA 09 098

Funding Number: PA 09 098
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Mechanisms of Alcohol and Nicotine Co Dependence (R01) Apply for PA 09 099

Funding Number: PA 09 099
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Manufacturing Processes of Medical, Dental, and Biological Technologies (SBIR R43/R44) Apply for PA 09 113

Funding Number: PA 09 113
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Manufacturing Processes of Medical, Dental, and Biological Technologies (STTR R41/R42) Apply for PA 09 114

Funding Number: PA 09 114
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R01) Apply for PA 09 106

Funding Number: PA 09 106
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R21) Apply for PA 09 107

Funding Number: PA 09 107
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
The Integrative Cancer Biology Program (ICBP) Centers for Cancer Systems Biology (CCSB) (U54) Apply for RFA CA 09 011

Funding Number: RFA CA 09 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $2,000,000
Clinical Research Curriculum Award (K30) Apply for RFA RR 09 006

Funding Number: RFA RR 09 006
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $275,000
Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R01) Apply for PA 09 122

Funding Number: PA 09 122
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biobehavioral Methods to Improve Outcomes Research (R21) Apply for PA 09 126

Funding Number: PA 09 126
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Exploratory Grants for Behavioral Research in Cancer Control (R21) Apply for PA 09 130

Funding Number: PA 09 130
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Interventions to Improve Palliative Care at the End of Life (R01) Apply for RFA NR 09 004

Funding Number: RFA NR 09 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $300,000
Incorporating Cost Effectiveness Analysis Into Factors Affecting Quality of Life Health Related Research (R01) Apply for RFA NR 09 005

Funding Number: RFA NR 09 005
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $300,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 436", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.